Signature(s)
Summary sheet
The proposed operation consists in an equity participation under EC MEDA II risk capital resources in two compartments of AlterMed: AlterMed Maghreb investing primarily in Morocco; and AlterMed Alternative Private Equity Fund (APEF) investing primarily in Tunisia.
The two compartments in which the Bank intends to invest display innovative features. AlterMed Maghreb will target primarily leveraged buy-outs (LBOs), thereby supporting a niche not fully covered by other funds in Morocco. AlterMed APEF will support companies to be listed in the Tunisian alternative market, an initiative expected to be implemented by the end of 2007 and strongly supported by the Tunisian government as an opportunity to substantially increase the capitalisation of the stock market, still in its infancy stage.
Not applicable
Not applicable
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).
News & Stories
General enquiries and comments
The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
Alternatively, the EIB can be contacted through its external offices.
Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.
Media enquiries
Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.
Complaints mechanism
Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.
Zero tolerance against fraud and corruption
The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.
Related publications